Tesamorelin (10mg)

$139.00

Quick Overview Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), designed to stimulate endogenous growth hormone secretion via the hypothalamic–pituitary axis. It enables controlled investigation of growth hormone dynamics and downstream metabolic pathways.

Quantity

Independent Certification

Each batch is verified through third-party analytical testing for accuracy and traceability

Discreet Shipping

Secure, unbranded packaging with controlled handling and fast domestic delivery

Research Use Only

Supplied strictly for laboratory research, analytical validation, and scientific investigation

Category:

Quick Overview

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), designed to stimulate endogenous growth hormone secretion via the hypothalamic–pituitary axis. It enables controlled investigation of growth hormone dynamics and downstream metabolic pathways.

Full Research Overview

Tesamorelin is a stabilized synthetic peptide analogue of endogenous growth hormone-releasing hormone (GHRH), engineered to promote pulsatile secretion of growth hormone (GH) from the anterior pituitary gland.

Read More

• Purity: ≥99% (High-Performance Liquid Chromatography verified)
• Form: Lyophilised powder
• Class: Growth Hormone-Releasing Hormone (GHRH) analogue
• Molecular Type: Synthetic peptide

Falutz, Julio, et al.
“Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients with Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial with a Safety Extension.”
The Journal of the American Medical Association (JAMA), 2010.
View Source

Stanley, Thomas L., et al.
“Effects of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients with Abdominal Fat Accumulation: A Randomized Controlled Trial.”
The Journal of the American Medical Association (JAMA), 2014.
View Source

Koutkia, Panayiotis, et al.
“Growth Hormone-Releasing Hormone in HIV-Infected Men with Lipodystrophy: A Randomized Controlled Trial.”
The Journal of Clinical Endocrinology & Metabolism, 2004.
View Source

This product is supplied strictly as a Research Use Only (RUO) material.

It is not approved by the Therapeutic Goods Administration (TGA) in Australia or the United States Food and Drug Administration (FDA) for human or veterinary use.

This product is not intended for human consumption, medical use, therapeutic application, or diagnostic purposes.

NŪ LABS does not provide:

  • Medical advice
  • Clinical recommendations
  • Dosage instructions
  • Treatment protocols
  • Reconstitution or administration guidance

All products are intended strictly for laboratory research, analytical validation, and scientific investigation purposes only.

Australian-Based

Locally operated supply with domestic fulfilment and support

Transparent Supply

Clear documentation and traceable sourcing with no hidden processes

Batch Verification

Every product linked to a unique batch ID with direct verification access

Third-Party Tested

All analytical data generated by independent laboratories, not internal sources